pharmaphorum9d
Bayer props up sagging radionuclide business with Noria acquisition
The Noria/PSMA deal gives the drugmaker a preclinical-stage alpha radionuclide compound based on actinium-225 and a small molecule directed towards prostate-specific membrane antigen (PSMA), a ...